NCT06635863View on ClinicalTrials.gov

Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions
Ventricular ArrythmiaNon-ischemic CardiomyopathyArrhythmogenic Inflammatory Cardiomyopathy
Interventions
DRUG

Prednisone 40mg

Prednisone 40mg x 8weeks

Trial Locations (1)

85006

Banner - University Medical Center, Phoenix campus, Phoenix

All Listed Sponsors
lead

Roderick Tung

OTHER